Cargando…

Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways

The tumor suppressor p53 normally acts as a brake to halt damaged cells from perpetrating their genetic errors into future generations. If p53 is disrupted by mutation, it may not only lose these corrective powers, but counterproductively acquire new capacities that drive cancer. A newly emerging ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Haupt, Sue, Raghu, Dinesh, Haupt, Ygal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728204/
https://www.ncbi.nlm.nih.gov/pubmed/26858938
http://dx.doi.org/10.3389/fonc.2016.00012
_version_ 1782412077383548928
author Haupt, Sue
Raghu, Dinesh
Haupt, Ygal
author_facet Haupt, Sue
Raghu, Dinesh
Haupt, Ygal
author_sort Haupt, Sue
collection PubMed
description The tumor suppressor p53 normally acts as a brake to halt damaged cells from perpetrating their genetic errors into future generations. If p53 is disrupted by mutation, it may not only lose these corrective powers, but counterproductively acquire new capacities that drive cancer. A newly emerging manner in which mutant p53 executes its cancer promoting functions is by harnessing key proteins, which normally partner with its wild type, tumor-inhibiting counterpart. In association with the subverted activities of these protein partners, mutant p53 is empowered to act across multiple fundamental cellular pathways (regulating cell division and metabolism) and corrupt them to become cancer promoting.
format Online
Article
Text
id pubmed-4728204
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-47282042016-02-08 Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways Haupt, Sue Raghu, Dinesh Haupt, Ygal Front Oncol Oncology The tumor suppressor p53 normally acts as a brake to halt damaged cells from perpetrating their genetic errors into future generations. If p53 is disrupted by mutation, it may not only lose these corrective powers, but counterproductively acquire new capacities that drive cancer. A newly emerging manner in which mutant p53 executes its cancer promoting functions is by harnessing key proteins, which normally partner with its wild type, tumor-inhibiting counterpart. In association with the subverted activities of these protein partners, mutant p53 is empowered to act across multiple fundamental cellular pathways (regulating cell division and metabolism) and corrupt them to become cancer promoting. Frontiers Media S.A. 2016-01-27 /pmc/articles/PMC4728204/ /pubmed/26858938 http://dx.doi.org/10.3389/fonc.2016.00012 Text en Copyright © 2016 Haupt, Raghu and Haupt. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Haupt, Sue
Raghu, Dinesh
Haupt, Ygal
Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
title Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
title_full Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
title_fullStr Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
title_full_unstemmed Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
title_short Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
title_sort mutant p53 drives cancer by subverting multiple tumor suppression pathways
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728204/
https://www.ncbi.nlm.nih.gov/pubmed/26858938
http://dx.doi.org/10.3389/fonc.2016.00012
work_keys_str_mv AT hauptsue mutantp53drivescancerbysubvertingmultipletumorsuppressionpathways
AT raghudinesh mutantp53drivescancerbysubvertingmultipletumorsuppressionpathways
AT hauptygal mutantp53drivescancerbysubvertingmultipletumorsuppressionpathways